RaeSedo, LLC
A revolutionary class of asthma therapeutics
TUCSON, United States · Founded 2020 · $3.4M raised
- Headquarters
- TUCSON, Arizona
- Employees
- 1–10
- Founded
- 2020
- Business Model
- B2G
- Website
- raesedoinc.com
- Total Funding
- $3.4M
- Last Round
- $3.4M GrantNov 2022
- Rounds
- 1
About
RaeSedo is a clinical-stage biopharmaceutical company developing a novel inhaled peptide therapeutic for asthma derived from surfactant protein-A (SP-A), a naturally occurring lung protein with innate immune properties. The company's lead candidate targets airway inflammation, mucus production, and bronchoconstriction across all asthma types. Founded by University of Arizona physician-scientists with over a decade of continuous NIH funding.
Summary
RaeSedo, LLC is a Biotech company based in TUCSON, United States, founded in 2020. It has raised $3.4M in total across 1 round, most recently a $3.4M Grant round in Nov 2022. Investors include National Institutes of Health.
Tech & App Stack
4 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Nov 2022
Investors
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Specialty pharmaceutical company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/raesedo-llc"><img src="https://indexed.vc/api/badge/company/raesedo-llc" alt="RaeSedo, LLC on Indexed.vc" width="260" height="76" /></a>